LEXARIA BIOSCIENCE CORP. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for the quarter ending 2022-02-28 was $1.20M.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for the quarter ending 2020-08-31 was $100.00K, a 3.38% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for the quarter ending 2019-08-31 was $103.50K, a 82.68% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for the quarter ending 2019-02-28 was $131.00K, a 28.58% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for fiscal 2022 was $1.20M, a 1311.76% increase from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for fiscal 2021 was $85.00K, a 15.00% decline from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for fiscal 2020 was $100.00K, a 57.36% decline from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, issued for services for fiscal 2019 was $234.50K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2022-08-31 | $1.20M 10-K · filed 2023-11-20 | |
| 2022-02-28 | $1.20M 10-Q · filed 2023-07-14 | |
| 2021-08-31 | $85.00K 10-K · filed 2022-11-28 | |
| 2020-08-31 | $100.00K 10-Q · filed 2021-07-15 | $100.00K 10-K · filed 2021-11-29 |
| 2019-08-31 | $103.50K 10-Q · filed 2020-06-29 | $234.50K 10-K · filed 2020-10-15 |
| 2019-02-28 | $131.00K 10-Q · filed 2020-06-29 | |
| 2018-08-31 | $597.63K 10-Q · filed 2019-07-08 | $781.06K 10-Q · filed 2020-01-09 |
| 2018-05-31 | $640.00K 10-Q · filed 2019-07-08 | |
| 2018-02-28 | $183.43K 10-Q · filed 2019-07-08 | |
| 2017-08-31 | $135.90K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $224.66K 10-K · filed 2018-11-14 |
| 2017-05-31 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-14 | $118.76K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-02-28 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-14 | |
| 2016-11-30 | $60.76K 10-Q · filed 2017-01-13 | |
| 2016-08-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $79.50K 10-K · filed 2018-11-14 |
| 2015-08-31 | $156.03K 10-K · filed 2016-11-29 | |
| 2013-10-31 | $11.20K 10-KT · filed 2014-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |